cjc 1295+ipamorelin CJC-1295 No DAC + Ipamorelin 10mg CJC-1295/Ipamorelin Guide - Dosing, Timing

IGF-1 LR3 is not appropriate for patients who are pregnant or breastfeeding, have active cancer or a cancer history (because IGF-1 stimulates cell growth broadly, including potentially malignant cells), have uncontrolled diabetes or diabetic retinopathy, or are under 21

Intended Use:For laboratory and research purposes only

Ready to give your skin the gift of renewal

Use a 31-gauge, 5/16-inch (8 mm) needle on a U-100 insulin syringe

The frequency of treatments may decrease as results are achieved, with maintenance sessions scheduled once every 3-4 weeks

The experiments were conducted independently at least three times